Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.82B.
ENTERPRISE VALUE (EV)
$3.82B
Regencell Bioscience Holdings Limited
Market Cap
$3.82B
Enterprise Value (EV)
$3.82B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Regencell Bioscience Holdings Limited (RGC) | $3.82B | $3.82B |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | $4.93B |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.02B | $3.93B |
| AbCellera Biologics Inc. (ABCL)vs › | $4.05B | $4.06B |
| Veracyte, Inc. (VCYT)vs › | $3.57B | $3.31B |
| LivaNova PLC (LIVN)vs › | $4.15B | $3.98B |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | $4.03B |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.51B | $3.19B |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.49B | $3.37B |
| Celcuity Inc. (CELC)vs › | $3.49B | $4.06B |
Market Cap
$3.82B
Total Debt
$312780.00
Cash
$2.42M
Enterprise Value
$3.82B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
